Zimmer Biomet Announces Fourth Quarter and Full-Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
Zimmer Biomet Holdings (ZBH) Misses Q4 EPS by 3c, Offers Guidance
February 7, 2022 6:35 AM ESTZimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $1.95, $0.03 worse than the analyst estimate of $1.98. Revenue for the quarter came in at $2.04 billion versus the consensus estimate of $2.07 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2022 EPS of $6.40-$6.80 vs 7.93 consensus.
2022... More